HONG KONG — A new Chinese study showing that enhancement of the natural generation of new neurons using a biodegradable material that allows the gradual release of a neurotrophic agent could represent a novel strategy for treating spinal cord injuries (SCI). Clinical trials of the approach may be imminent.
HONG KONG – A new Chinese study showing that enhancement of the natural generation of new neurons using a biodegradable material that allows the gradual release of a neurotrophic agent could represent a novel strategy for treating spinal cord injuries (SCI). Clinical trials of the approach may be imminent.
HONG KONG — A new multiethnic genomewide association study (GWAS) by an international research consortium has identified 12 new genetic loci influencing blood pressure and indicated a role for DNA methylation in blood pressure regulation, which could have important implications for the development of new antihypertensive treatments.
HONG KONG — For the first time, biologists have successfully developed functioning whole kidneys with a urinary excretion pathway from human stem cell-generated embryonic kidneys, Japanese researchers reported in the Proceedings of the National Academy of Sciences.
HONG KONG — For the first time, biologists have successfully developed functioning whole kidneys with a urinary excretion pathway from human stem cell-generated embryonic kidneys, Japanese researchers reported in the Proceedings of the National Academy of Sciences.
HONG KONG – A new multiethnic genomewide association study (GWAS) by an international research consortium has identified 12 new genetic loci influencing blood pressure and indicated a role for DNA methylation in blood pressure regulation, which could have important implications for the development of new antihypertensive treatments.
HONG KONG — A new peptide-based drug delivery system has been shown for the first time to enable therapeutic proteins and possibly other drugs to cross the blood-brain barrier (BBB), which may help in treating multiple sclerosis (MS) and other central nervous system (CNS) disorders such as Alzheimer’s disease and Parkinson’s disease, Korean researchers reported.
HONG KONG — A new peptide-based drug delivery system has been shown for the first time to enable therapeutic proteins and possibly other drugs to cross the blood-brain barrier (BBB), which may help in treating multiple sclerosis (MS) and other central nervous system (CNS) disorders such as Alzheimer's disease and Parkinson's disease, Korean researchers reported.
